Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Apr 2;584(7):1399-404.
doi: 10.1016/j.febslet.2009.12.025. Epub 2009 Dec 22.

Chaperone-mediated autophagy in health and disease

Maria Kon  1 , Ana Maria Cuervo
Affiliations
Review

Chaperone-mediated autophagy in health and disease

Maria Kon et al. FEBS Lett. .

Abstract

Chaperone-mediated autophagy (CMA) is a lysosomal pathway that participates in the degradation of cytosolic proteins. CMA is activated by starvation and in response to stressors that result in protein damage. The selectivity intrinsic to CMA allows for removal of damaged proteins without disturbing nearby functional ones. CMA works in a coordinated manner with other autophagic pathways, which can compensate for each other. Interest in CMA has recently grown because of the connections established between this autophagic pathway and human pathologies. Here we review the unique properties of CMA compared to other autophagic pathways and its relevance in health and disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Chaperone-mediated autophagy, basic components and regulation. (a) Steps on CMA
The two essential components of CMA are the cargo recognition complex (in the cytosol) and the cargo translocation complex (at the lysosomal membrane). The CMA targeting motif (KFERQ-like) in the substrate protein is recognized by cytosolic hsc70, main component of the cargo recognition complex, and this delivers it to the surface of the lysosomes where it binds to LAMP-2A. This single span membrane protein and a luminal form of hsc70 (lys-hsc70) are the major components of the cargo translocation complex. Whereas substrate proteins bind to monomeric forms of LAMP-2A, organization of LAMP-2A into high order multimeric complexes is required for substrate translocation. Once in the lumen the substrate is rapidly degraded. (b–c) Regulation of CMA. CMA activity is directly dependent on the amount of LAMP-2A molecules available at the lysosomal membrane. Levels of LAMP-2A are regulated by de novo synthesis (not depicted here), through changes in their regulated Cathepsin A-dependent degradation at the lysosomal membrane (b) and by the direct insertion of a luminal resident pool of LAMP-2A into the lysosomal membrane (c).
Figure 2
Figure 2. Contribution of CMA dysfunction to pathogenesis in neurodegeneration
Different pathogenic proteins (α-synuclein and Tau) depicted here, have been shown to have a primary detrimental effect on CMA activity. Whereas wild-type or unmodified forms of these proteins (green circles) can be targeted and taken up by lysosomes via CMA (a), their pathogenic counterparts (brown circles) are delivered to the CMA translocation complex at the lysosomal membrane but fail to translocate into the lumen (b). These pathogenic proteins often organize into irreversible oligomeric complexes at the lysosomal membrane that further block CMA activity. Cells respond to CMA blockage by upregulating macroautophagy, the only proteolytic pathway that can directly degrade proteinaceous inclusions and aggregates (b). Failure of macroautophagy with time – due to exhaustion or primary damage by the pathogenic proteins – could precipitate progression of disease (c).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ciechanover A. Proteolysis: from the lysosome to ubiquitin and the proteasome. Nat Rev Mol Cell Biol. 2005;6:79–87. - PubMed
    1. Goldberg AL. Protein degradation and protection against misfolded or damaged proteins. Nature. 2003;18:895–899. - PubMed
    1. Mizushima N, Levine B, Cuervo A, Klionsky D. Autophagy fights disease through cellular self-digestion. Nature. 2008;451:1069–75. - PMC - PubMed
    1. Cuervo AM. Chaperone-mediated autophagy: selectivity pays off. Trends Endocrinol Metab. 2009 E-pub ahead of publication. - PMC - PubMed
    1. Dice J. Chaperone-mediated autophagy. Autophagy. 2007;3:295–9. - PubMed

Publication types

Substances